Latest news
AstraZeneca (LSE:AZN) Stock Could Sit Below Fair Value Despite Strong Returns - simplywall.stsimplywall.st · Sat, 08 Aug 2026 14:58:41 GMTAstraZeneca (LSE:AZN) Merger Talk Fades, Is The Stock Undervalued? - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 15:16:33 GMTAstraZeneca PLC Stock 12‑Month Price Target Raised to $216.47, Implies 34% Upside - TradingViewTradingView · Fri, 07 Aug 2026 03:20:00 GMTAstraZeneca obesity pill cuts body weight by 10.5% in phase II trial - investingLiveinvestingLive · Thu, 06 Aug 2026 20:31:00 GMTConsensus Analysis | Astra Zeneca | 6 August 2026 - BiostockBiostock · Thu, 06 Aug 2026 14:57:19 GMTSoriot should explain the curious case of AstraZeneca’s non-deal - The GuardianThe Guardian · Thu, 06 Aug 2026 01:30:00 GMTAstraZeneca Share Price Falls Up To 9% On Bristol Myers Merger Reports: What It Means For ISA And SIPP Holders - ig.comig.com · Tue, 04 Aug 2026 14:26:50 GMTMy AstraZeneca shares just crashed 9.7%! Here’s why I’m NOT selling - The Twelfth MagpieThe Twelfth Magpie · Tue, 04 Aug 2026 10:50:31 GMT